190 related articles for article (PubMed ID: 30664843)
21. Visual improvement after cultivated oral mucosal epithelial transplantation.
Sotozono C; Inatomi T; Nakamura T; Koizumi N; Yokoi N; Ueta M; Matsuyama K; Miyakoda K; Kaneda H; Fukushima M; Kinoshita S
Ophthalmology; 2013 Jan; 120(1):193-200. PubMed ID: 23084239
[TBL] [Abstract][Full Text] [Related]
22. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects.
Ling JD; Gire A; Pflugfelder SC
Am J Ophthalmol; 2013 Apr; 155(4):615-619, 619.e1-2. PubMed ID: 23218704
[TBL] [Abstract][Full Text] [Related]
23. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Versus Standard of Care for Postsurgical Lagophthalmos and Exposure Keratopathy: Trends in Visual Outcomes.
Gervasio KA; Godfrey KJ; Marlow ED; Lee MN; Lelli GJ
Ophthalmic Plast Reconstr Surg; 2019; 35(3):281-285. PubMed ID: 30289823
[TBL] [Abstract][Full Text] [Related]
24. Fluid filled scleral contact lens in pediatric patients: challenges and outcome.
Rathi VM; Mandathara PS; Vaddavalli PK; Srikanth D; Sangwan VS
Cont Lens Anterior Eye; 2012 Aug; 35(4):189-92. PubMed ID: 22459875
[TBL] [Abstract][Full Text] [Related]
25. Role of Scleral Contact Lenses in Management of Coexisting Keratoconus and Stevens-Johnson Syndrome.
Rathi VM; Taneja M; Dumpati S; Mandathara PS; Sangwan VS
Cornea; 2017 Oct; 36(10):1267-1269. PubMed ID: 28749897
[TBL] [Abstract][Full Text] [Related]
26. Corneal Limbal Stem Cell Deficiency in Children with Stevens-Johnson Syndrome.
Choi SH; Kim MK; Oh JY
Am J Ophthalmol; 2019 Mar; 199():1-8. PubMed ID: 30347185
[TBL] [Abstract][Full Text] [Related]
27. Regression of corneal opacity and neovascularization in Stevens-Johnson syndrome and Toxic Epidermal Necrolysis with the use of prosthetic replacement of the ocular surface ecosystem (PROSE) treatment.
Liao J; Asghari B; Carrasquillo KG
Am J Ophthalmol Case Rep; 2022 Jun; 26():101520. PubMed ID: 35464679
[TBL] [Abstract][Full Text] [Related]
28. The outcomes of corneal sight rehabilitating surgery in Stevens-Johnson syndrome: case series.
Peng R; Chi M; Xiao G; Qu H; Shen Z; Zhao Y; Hong J
BMC Ophthalmol; 2024 May; 24(1):205. PubMed ID: 38711013
[TBL] [Abstract][Full Text] [Related]
29. Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis: a case-control study.
Hsu M; Jayaram A; Verner R; Lin A; Bouchard C
Cornea; 2012 Dec; 31(12):1394-402. PubMed ID: 23135531
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant Role of Amniotic Membrane Transplantation in Acute Ocular Stevens-Johnson Syndrome: A Randomized Control Trial.
Sharma N; Thenarasun SA; Kaur M; Pushker N; Khanna N; Agarwal T; Vajpayee RB
Ophthalmology; 2016 Mar; 123(3):484-91. PubMed ID: 26686968
[TBL] [Abstract][Full Text] [Related]
31. Diagnoses and Outcomes of Prosthetic Replacement of the Ocular Surface Ecosystem Treatment-A Canadian Experience.
Wong BM; Garg A; Trinh T; Mimouni M; Ramdass S; Liao J; Chandrakumar M; Chan CC; Slomovic AR
Eye Contact Lens; 2021 Jul; 47(7):394-400. PubMed ID: 33769992
[TBL] [Abstract][Full Text] [Related]
32. The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease.
Hall LN; Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Ocul Surf; 2021 Jan; 19():128-132. PubMed ID: 32445836
[TBL] [Abstract][Full Text] [Related]
33. Treatment Modalities and Clinical Outcomes in Ocular Sequelae of Stevens-Johnson Syndrome Over 25 Years--A Paradigm Shift.
Iyer G; Srinivasan B; Agarwal S; Pillai VS; Ahuja A
Cornea; 2016 Jan; 35(1):46-50. PubMed ID: 26555585
[TBL] [Abstract][Full Text] [Related]
34. PROSE for irregular corneas at a tertiary eye care center.
Arumugam AO; Rajan R; Subramanian M; Mahadevan R
Eye Contact Lens; 2014 Mar; 40(2):71-3. PubMed ID: 24418864
[TBL] [Abstract][Full Text] [Related]
35. Prosthetic replacement of the ocular surface ecosystem for corneal irregularity: Visual improvement and optical device characteristics.
Kumar P; Mohamed A; Bhombal F; Dumpati S; Vaddavalli PK
Cont Lens Anterior Eye; 2019 Oct; 42(5):526-532. PubMed ID: 31146970
[TBL] [Abstract][Full Text] [Related]
36. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment for Complications After LASIK.
Mian SZ; Agranat JS; Jacobs DS
Eye Contact Lens; 2016 Nov; 42(6):371-373. PubMed ID: 27466722
[TBL] [Abstract][Full Text] [Related]
37. Patient ocular conditions and clinical outcomes using a PROSE scleral device.
Dimit R; Gire A; Pflugfelder SC; Bergmanson JP
Cont Lens Anterior Eye; 2013 Aug; 36(4):159-63. PubMed ID: 23499361
[TBL] [Abstract][Full Text] [Related]
38. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) for Visual Rehabilitation in Limbal Stem Cell Deficiency.
Kim KH; Deloss KS; Hood CT
Eye Contact Lens; 2020 Nov; 46(6):359-363. PubMed ID: 32097183
[TBL] [Abstract][Full Text] [Related]
39. The relation between visual performance and clinical ocular manifestations in Stevens-Johnson syndrome.
Kaido M; Yamada M; Sotozono C; Kinoshita S; Shimazaki J; Tagawa Y; Hara Y; Chikama T; Tsubota K
Am J Ophthalmol; 2012 Sep; 154(3):499-511.e1. PubMed ID: 22818907
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Descemetocele Management With Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment.
Xu M; Randleman JB; Chiu GB
Eye Contact Lens; 2020 Mar; 46(2):e7-e10. PubMed ID: 30985491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
